Treatment With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (Pcsk9-I) In Clinical Routine – New Data Regarding Familial Hypercholesterolaemia (Fh) Genotype Safety And Efficacy. (August 2019)

Record Type:: Journal Article
Title:: Treatment With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (Pcsk9-I) In Clinical Routine – New Data Regarding Familial Hypercholesterolaemia (Fh) Genotype Safety And Efficacy. (August 2019)
Main Title:: Treatment With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (Pcsk9-I) In Clinical Routine – New Data Regarding Familial Hypercholesterolaemia (Fh) Genotype Safety And Efficacy
Authors:: Schumann, F.
Hollstein, T.
Steinhagen-Thiessen, E.
Kassner, U.
Abstract:
Is Part Of:: Atherosclerosis. Volume 287(2019)
Journal:: Atherosclerosis
Issue:: Volume 287(2019)
Issue Display:: Volume 287, Issue 2019 (2019)
Year:: 2019
Volume:: 287
Issue:: 2019
Issue Sort Value:: 2019-0287-2019-0000
Page Start:: e215
Page End:: e216
Publication Date:: 2019-08
Subjects:: Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:: http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.atherosclerosis.2019.06.656 ↗
Languages:: English
ISSNs:: 0021-9150
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 16388.xml